vs
AMPCO PITTSBURGH CORP（AP）与Apellis Pharmaceuticals, Inc.（APLS）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是AMPCO PITTSBURGH CORP的1.9倍（$199.9M vs $104.4M），Apellis Pharmaceuticals, Inc.净利率更高（-29.5% vs -55.2%，领先25.8%），AMPCO PITTSBURGH CORP同比增速更快（11.5% vs -5.9%），AMPCO PITTSBURGH CORP自由现金流更多（$-64.0K vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -2.6%）
安普科匹兹堡公司是一家特种钢材制造商，总部位于宾夕法尼亚州匹兹堡市中心，1929年由多家此前已成立的小型钢铁企业合并组建而成。需要注意区分它和其他同样带有Ampco名称的企业，比如位于密尔沃基的铜基合金生产商、迈阿密的橱柜企业等。
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
AP vs APLS — 直观对比
营收规模更大
APLS
是对方的1.9倍
$104.4M
营收增速更快
AP
高出17.4%
-5.9%
净利率更高
APLS
高出25.8%
-55.2%
自由现金流更多
AP
多$14.2M
$-14.3M
两年增速更快
APLS
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.4M | $199.9M |
| 净利润 | $-57.7M | $-59.0M |
| 毛利率 | — | — |
| 营业利润率 | -54.0% | -25.6% |
| 净利率 | -55.2% | -29.5% |
| 营收同比 | 11.5% | -5.9% |
| 净利润同比 | -1958.9% | -62.2% |
| 每股收益（稀释后） | $-2.87 | $-0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APAPLS
| Q4 25 | $104.4M | $199.9M | ||
| Q3 25 | $103.7M | $458.6M | ||
| Q2 25 | $108.9M | $178.5M | ||
| Q1 25 | $99.2M | $166.8M | ||
| Q4 24 | $93.6M | $212.5M | ||
| Q3 24 | $92.1M | $196.8M | ||
| Q2 24 | $107.1M | $199.7M | ||
| Q1 24 | $110.0M | $172.3M |
净利润APAPLS
| Q4 25 | $-57.7M | $-59.0M | ||
| Q3 25 | $-2.2M | $215.7M | ||
| Q2 25 | $-7.3M | $-42.2M | ||
| Q1 25 | $1.1M | $-92.2M | ||
| Q4 24 | $3.1M | $-36.4M | ||
| Q3 24 | $-2.0M | $-57.4M | ||
| Q2 24 | $2.0M | $-37.7M | ||
| Q1 24 | $-2.7M | $-66.4M |
营业利润率APAPLS
| Q4 25 | -54.0% | -25.6% | ||
| Q3 25 | 1.1% | 48.7% | ||
| Q2 25 | -2.8% | -18.6% | ||
| Q1 25 | 3.9% | -50.0% | ||
| Q4 24 | 5.5% | -12.3% | ||
| Q3 24 | 2.0% | -24.0% | ||
| Q2 24 | 4.7% | -14.7% | ||
| Q1 24 | 0.1% | -36.0% |
净利率APAPLS
| Q4 25 | -55.2% | -29.5% | ||
| Q3 25 | -2.1% | 47.0% | ||
| Q2 25 | -6.7% | -23.6% | ||
| Q1 25 | 1.2% | -55.3% | ||
| Q4 24 | 3.3% | -17.1% | ||
| Q3 24 | -2.1% | -29.2% | ||
| Q2 24 | 1.9% | -18.9% | ||
| Q1 24 | -2.5% | -38.5% |
每股收益（稀释后）APAPLS
| Q4 25 | $-2.87 | $-0.40 | ||
| Q3 25 | $-0.11 | $1.67 | ||
| Q2 25 | $-0.36 | $-0.33 | ||
| Q1 25 | $0.06 | $-0.74 | ||
| Q4 24 | $0.16 | $-0.30 | ||
| Q3 24 | $-0.10 | $-0.46 | ||
| Q2 24 | $0.10 | $-0.30 | ||
| Q1 24 | $-0.14 | $-0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $466.2M |
| 总债务越低越好 | $117.9M | — |
| 股东权益账面价值 | $32.6M | $370.1M |
| 总资产 | $495.4M | $1.1B |
| 负债/权益比越低杠杆越低 | 3.61× | — |
8季度趋势，按日历期对齐
现金及短期投资APAPLS
| Q4 25 | $10.7M | $466.2M | ||
| Q3 25 | $15.0M | $479.2M | ||
| Q2 25 | $9.9M | $370.0M | ||
| Q1 25 | $7.1M | $358.4M | ||
| Q4 24 | $15.4M | $411.3M | ||
| Q3 24 | $11.8M | $396.9M | ||
| Q2 24 | $7.9M | $360.1M | ||
| Q1 24 | $10.8M | $325.9M |
总债务APAPLS
| Q4 25 | $117.9M | — | ||
| Q3 25 | $119.0M | — | ||
| Q2 25 | $115.9M | — | ||
| Q1 25 | $115.0M | — | ||
| Q4 24 | $116.4M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $119.4M | — | ||
| Q1 24 | $116.2M | $93.1M |
股东权益APAPLS
| Q4 25 | $32.6M | $370.1M | ||
| Q3 25 | $60.1M | $401.2M | ||
| Q2 25 | $62.7M | $156.3M | ||
| Q1 25 | $64.6M | $164.2M | ||
| Q4 24 | $58.9M | $228.5M | ||
| Q3 24 | $61.3M | $237.1M | ||
| Q2 24 | $58.0M | $264.3M | ||
| Q1 24 | $56.3M | $266.7M |
总资产APAPLS
| Q4 25 | $495.4M | $1.1B | ||
| Q3 25 | $524.4M | $1.1B | ||
| Q2 25 | $537.2M | $821.4M | ||
| Q1 25 | $536.2M | $807.3M | ||
| Q4 24 | $530.9M | $885.1M | ||
| Q3 24 | $547.4M | $901.9M | ||
| Q2 24 | $560.8M | $904.5M | ||
| Q1 24 | $565.8M | $831.9M |
负债/权益比APAPLS
| Q4 25 | 3.61× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.78× | — | ||
| Q4 24 | 1.98× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 2.06× | — | ||
| Q1 24 | 2.06× | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $-14.2M |
| 自由现金流经营现金流 - 资本支出 | $-64.0K | $-14.3M |
| 自由现金流率自由现金流/营收 | -0.1% | -7.1% |
| 资本支出强度资本支出/营收 | 2.7% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.1M | $45.0M |
8季度趋势，按日历期对齐
经营现金流APAPLS
| Q4 25 | $2.7M | $-14.2M | ||
| Q3 25 | $6.3M | $108.5M | ||
| Q2 25 | $-2.3M | $4.4M | ||
| Q1 25 | $-5.3M | $-53.4M | ||
| Q4 24 | $7.5M | $19.4M | ||
| Q3 24 | $11.4M | $34.1M | ||
| Q2 24 | $-5.3M | $-8.3M | ||
| Q1 24 | $4.5M | $-133.0M |
自由现金流APAPLS
| Q4 25 | $-64.0K | $-14.3M | ||
| Q3 25 | $3.3M | $108.3M | ||
| Q2 25 | $-3.8M | $4.4M | ||
| Q1 25 | $-7.5M | $-53.4M | ||
| Q4 24 | $3.7M | $19.3M | ||
| Q3 24 | $8.4M | — | ||
| Q2 24 | $-8.0M | $-8.4M | ||
| Q1 24 | $1.7M | $-133.3M |
自由现金流率APAPLS
| Q4 25 | -0.1% | -7.1% | ||
| Q3 25 | 3.2% | 23.6% | ||
| Q2 25 | -3.5% | 2.5% | ||
| Q1 25 | -7.5% | -32.0% | ||
| Q4 24 | 4.0% | 9.1% | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | -7.5% | -4.2% | ||
| Q1 24 | 1.5% | -77.3% |
资本支出强度APAPLS
| Q4 25 | 2.7% | 0.1% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 1.3% | 0.0% | ||
| Q1 25 | 2.2% | 0.0% | ||
| Q4 24 | 4.0% | 0.0% | ||
| Q3 24 | 3.2% | 0.0% | ||
| Q2 24 | 2.5% | 0.0% | ||
| Q1 24 | 2.6% | 0.2% |
现金转化率APAPLS
| Q4 25 | — | — | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.62× | — | ||
| Q4 24 | 2.40× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.64× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
